Glassman Wealth Services Catalyst Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$3.45 - $4.69 $39,123 - $53,184	-11,340 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$3.89 - $7.43 $7,624 - $14,562	-1,960 Reduced 14.74%	11,340 $60,000
Q2 2019 Aug 08, 2019	BUY	$2.7 - $6.11 $2,700 - $6,110	1,000 Added 8.13%	13,300 $51,000
Q4 2018 Feb 06, 2019	BUY	$1.92 - $3.62 $23,616 - $44,526	12,300 New	12,300 $24,000

336

95.5M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.41B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.